These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 24924145)

  • 41. Prediction of outcome by highly sensitive troponin T in outpatients with chronic systolic left ventricular heart failure.
    Egstrup M; Schou M; Tuxen CD; Kistorp CN; Hildebrandt PR; Gustafsson F; Faber J; Goetze JP; Gustafsson I
    Am J Cardiol; 2012 Aug; 110(4):552-7. PubMed ID: 22579083
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Prognostic value of discharge hemoglobin level in patients hospitalized for acute heart failure].
    Sánchez-Torrijos J; Gudín-Uriel M; Nadal-Barangé M; Jacas-Osborn V; Trigo-Bautista A; Giménez-Alcalá M; Payá-Serrano R; Ridocci-Soriano F
    Rev Esp Cardiol; 2006 Dec; 59(12):1276-82. PubMed ID: 17194423
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Parameters influencing in-hospital mortality in patients hospitalized in intensive cardiac care unit: is there an influence of anemia and iron deficiency?
    Uscinska E; Sobkowicz B; Sawicki R; Kiluk I; Baranicz M; Stepek T; Dabrowska M; Szmitkowski M; Musial WJ; Tycinska AM
    Intern Emerg Med; 2015 Apr; 10(3):337-44. PubMed ID: 25502592
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Brain natriuretic peptide between traditional and nontraditional risk factors in hemodialysis patients: analysis of cardiovascular mortality in a two-year follow-up.
    Selim G; Stojceva-Taneva O; Spasovski G; Georgievska-Ismail L; Zafirovska-Ivanovska B; Gelev S; Dzekova P; Trajcevska L; Trojacanec-Piponska S; Sikole A
    Nephron Clin Pract; 2011; 119(2):c162-70. PubMed ID: 21757955
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure.
    Kistorp C; Faber J; Galatius S; Gustafsson F; Frystyk J; Flyvbjerg A; Hildebrandt P
    Circulation; 2005 Sep; 112(12):1756-62. PubMed ID: 16157772
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Iron deficiency anemia and cardiac mortality in patients with left ventricular systolic dysfunction undergoing coronary stenting.
    Varma A; Appleton DL; Nusca A; Lipinski MJ; Goudreau E; Cowley MJ; Wittkamp M; Vetrovec GW; Abbate A
    Minerva Cardioangiol; 2010 Feb; 58(1):1-10. PubMed ID: 20145590
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of the prognostic usefulness of N-terminal pro-brain natriuretic Peptide in patients with heart failure with versus without chronic kidney disease.
    Bruch C; Fischer C; Sindermann J; Stypmann J; Breithardt G; Gradaus R
    Am J Cardiol; 2008 Aug; 102(4):469-74. PubMed ID: 18678308
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Iron deficiency in Taiwanese patients with heart failure and reduced ejection fraction.
    Sung HP; Hsu CY; Lee YH; Lin PL; Liao CT; Chung FP; Ko SL; Huang CY; Lin KC; Chang HY
    J Chin Med Assoc; 2023 Aug; 86(8):725-731. PubMed ID: 37314316
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ongoing myocardial injury in stable severe heart failure: value of cardiac troponin T monitoring for high-risk patient identification.
    Perna ER; Macin SM; Canella JP; Augier N; Stival JL; Cialzeta JR; Pitzus AE; Garcia EH; Obregón R; Brizuela M; Barbagelata A
    Circulation; 2004 Oct; 110(16):2376-82. PubMed ID: 15477403
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intravenous iron without erythropoietin for the treatment of iron deficiency anemia in patients with moderate to severe congestive heart failure and chronic kidney insufficiency.
    Usmanov RI; Zueva EB; Silverberg DS; Shaked M
    J Nephrol; 2008; 21(2):236-42. PubMed ID: 18446719
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Iron deficiency defined as depleted iron stores accompanied by unmet cellular iron requirements identifies patients at the highest risk of death after an episode of acute heart failure.
    Jankowska EA; Kasztura M; Sokolski M; Bronisz M; Nawrocka S; Oleśkowska-Florek W; Zymliński R; Biegus J; Siwołowski P; Banasiak W; Anker SD; Filippatos G; Cleland JG; Ponikowski P
    Eur Heart J; 2014 Sep; 35(36):2468-76. PubMed ID: 24927731
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic value of plasma renin activity in heart failure patients with chronic kidney disease.
    Poletti R; Vergaro G; Zyw L; Prontera C; Passino C; Emdin M
    Int J Cardiol; 2013 Aug; 167(3):711-5. PubMed ID: 22459392
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial.
    Okonko DO; Grzeslo A; Witkowski T; Mandal AK; Slater RM; Roughton M; Foldes G; Thum T; Majda J; Banasiak W; Missouris CG; Poole-Wilson PA; Anker SD; Ponikowski P
    J Am Coll Cardiol; 2008 Jan; 51(2):103-12. PubMed ID: 18191732
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
    Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E
    Am J Cardiol; 2008 Sep; 102(6):733-7. PubMed ID: 18773998
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Criteria for Iron Deficiency in Patients With Heart Failure.
    Masini G; Graham FJ; Pellicori P; Cleland JGF; Cuthbert JJ; Kazmi S; Inciardi RM; Clark AL
    J Am Coll Cardiol; 2022 Feb; 79(4):341-351. PubMed ID: 35086656
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial.
    Hartmann F; Packer M; Coats AJ; Fowler MB; Krum H; Mohacsi P; Rouleau JL; Tendera M; Castaigne A; Anker SD; Amann-Zalan I; Hoersch S; Katus HA
    Circulation; 2004 Sep; 110(13):1780-6. PubMed ID: 15381643
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Iron deficiency and hematinic deficiencies in atrial fibrillation: A new insight into comorbidities.
    Keskin M; Ural D; Altay S; Argan O; Börklü EB; Kozan Ö
    Turk Kardiyol Dern Ars; 2018 Mar; 46(2):103-110. PubMed ID: 29512626
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of tricuspid regurgitation on survival in patients with chronic heart failure: unexpected findings of a long-term observational study.
    Neuhold S; Huelsmann M; Pernicka E; Graf A; Bonderman D; Adlbrecht C; Binder T; Maurer G; Pacher R; Mascherbauer J
    Eur Heart J; 2013 Mar; 34(11):844-52. PubMed ID: 23335604
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The prevalence of anemia and iron deficiency in IBD outpatients in Scandinavia.
    Bager P; Befrits R; Wikman O; Lindgren S; Moum B; Hjortswang H; Dahlerup JF
    Scand J Gastroenterol; 2011 Mar; 46(3):304-9. PubMed ID: 21073374
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Iron deficiency and anaemia in heart failure: understanding the FAIR-HF trial.
    González-Costello J; Comín-Colet J
    Eur J Heart Fail; 2010 Nov; 12(11):1159-62. PubMed ID: 20855375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.